CLINICAL_TRIALS
trial_result
· 2016-03-04
Clinical Trial Update: A Multiple Dose Study of Grazoprevir (MK-5172) in Hepatitis C-Infected Participants (MK-5172-010) [Phase 1]
Summary
Phase 1 multiple-dose study of Grazoprevir (MK-5172) in hepatitis C-infected participants has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED | Results posted: 2016-03-04